Keywords: biochem, succeeds, patent, war, emory, pharma, says

BioChem succeeds in patent war with Emory

Article | 12 August 1999

BioChem Pharma says that it has succeeded in invalidating EmoryUniversity's Australian patent application relating to its antiviral compound lamivudine. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Epivir

Lamivudine

Go to drug listing